QUAINI, Federico
 Distribuzione geografica
Continente #
NA - Nord America 15.126
AS - Asia 12.562
EU - Europa 9.402
SA - Sud America 1.707
AF - Africa 616
Continente sconosciuto - Info sul continente non disponibili 327
OC - Oceania 34
Totale 39.774
Nazione #
US - Stati Uniti d'America 14.665
SG - Singapore 4.329
CN - Cina 3.481
VN - Vietnam 2.069
IT - Italia 1.763
IE - Irlanda 1.390
BR - Brasile 1.297
SE - Svezia 1.297
FI - Finlandia 1.209
DE - Germania 1.066
HK - Hong Kong 904
UA - Ucraina 667
FR - Francia 646
BD - Bangladesh 527
ZA - Sudafrica 399
NL - Olanda 353
TR - Turchia 314
CA - Canada 282
GB - Regno Unito 262
IN - India 222
AT - Austria 161
AR - Argentina 150
RU - Federazione Russa 149
MX - Messico 96
BE - Belgio 94
IQ - Iraq 83
JP - Giappone 75
CI - Costa d'Avorio 74
EC - Ecuador 74
PH - Filippine 68
PL - Polonia 67
CZ - Repubblica Ceca 65
PK - Pakistan 65
CO - Colombia 56
ID - Indonesia 53
KR - Corea 51
ES - Italia 50
TH - Thailandia 49
VE - Venezuela 42
UZ - Uzbekistan 40
MA - Marocco 35
AU - Australia 30
SA - Arabia Saudita 30
LT - Lituania 29
JO - Giordania 27
PY - Paraguay 27
IR - Iran 25
CH - Svizzera 24
TN - Tunisia 23
TW - Taiwan 22
CL - Cile 21
KE - Kenya 21
EG - Egitto 20
UY - Uruguay 20
EU - Europa 18
AZ - Azerbaigian 17
OM - Oman 15
HN - Honduras 13
MY - Malesia 13
AL - Albania 12
HU - Ungheria 11
IL - Israele 11
KZ - Kazakistan 11
NP - Nepal 11
PE - Perù 11
AE - Emirati Arabi Uniti 10
BG - Bulgaria 10
BY - Bielorussia 10
JM - Giamaica 10
RO - Romania 10
BO - Bolivia 9
CR - Costa Rica 9
DZ - Algeria 9
ET - Etiopia 9
LU - Lussemburgo 9
RS - Serbia 9
DO - Repubblica Dominicana 8
GT - Guatemala 7
LB - Libano 7
NG - Nigeria 7
GR - Grecia 6
NI - Nicaragua 6
TT - Trinidad e Tobago 6
KG - Kirghizistan 5
KH - Cambogia 5
PA - Panama 5
PT - Portogallo 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
SV - El Salvador 5
EE - Estonia 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BH - Bahrain 3
MD - Moldavia 3
MK - Macedonia 3
Totale 39.422
Città #
Singapore 2.240
Ashburn 1.639
San Jose 1.404
Dublin 1.385
Chandler 1.322
Dallas 1.014
Santa Clara 878
Hong Kong 863
Beijing 804
Jacksonville 768
Dearborn 633
Ho Chi Minh City 607
Parma 581
Council Bluffs 523
Boardman 510
Hanoi 470
Ann Arbor 445
Johannesburg 376
Nanjing 376
New York 364
Munich 313
Los Angeles 300
Lauterbourg 260
Shanghai 256
Princeton 253
Izmir 229
Wilmington 227
Helsinki 188
San Mateo 166
Toronto 142
Hefei 141
Bremen 135
Buffalo 134
Vienna 133
São Paulo 121
Jinan 112
Milan 109
Nanchang 102
Seattle 102
Kunming 93
Shenyang 93
Brussels 92
Haiphong 85
Bologna 81
Da Nang 81
Moscow 75
Abidjan 74
Hebei 74
Changsha 73
Frankfurt am Main 70
Columbus 69
Guangzhou 67
Des Moines 64
Rome 62
Turku 62
Tianjin 61
London 58
Chicago 57
Padova 57
Atlanta 54
Brooklyn 54
Jiaxing 54
Marseille 53
Houston 52
The Dalles 51
Tokyo 50
Warsaw 50
Montreal 49
Woodbridge 49
Nuremberg 48
Phoenix 43
Modena 40
Norwalk 40
Denver 39
Chennai 37
Hangzhou 37
Orem 36
Tulsa 36
Amsterdam 35
Baghdad 35
Zhengzhou 35
Boston 34
Tashkent 33
Biên Hòa 32
Hải Dương 32
Rio de Janeiro 32
Seoul 31
Belo Horizonte 29
Fremont 29
Lahore 29
Ningbo 29
Pune 29
Düsseldorf 28
Brno 27
Dong Ket 26
Jakarta 26
Poplar 26
Stockholm 26
Falkenstein 25
Guayaquil 25
Totale 23.598
Nome #
Cobalt oxide nanoparticles induce oxidative stress and alter electromechanical function in rat ventricular myocytes 462
Effects of standardized green tea extract and its main component, EGCG, on mitochondrial function and contractile performance of healthy rat cardiomyocytes 302
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol 293
Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart 277
Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction. 272
Comet assay and prediction of clinical outcome after DNA-damaging drugs treatment 265
Diabetes impairs hematopoietic stem cell mobilization by altering niche function 258
Cardiac stem cell disease in diabetic cardiomyopathy: perspectives for preventing cardiac morpho-functional remodelling 251
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 247
Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue 243
Acute Myocardial Infarction in Humans is Associated with Activation of Programmed Myocyte Cell Death in the Surviving Portion of the Heart 238
Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats 234
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 231
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors 222
1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients 220
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 216
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 214
Isolation and characterization of circulating tumor cells in advanced squamous-cell carcinoma of the lung 210
L’autofagia coinvolge i cardiomiociti e le cellule progenitrici nella cardiomiopatia indotta da imatinib mesilato 207
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 207
Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non–Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors 206
227P Sexual dimorphism in immune profile of early and advanced NSCLC 205
1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy 204
Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart 203
Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling. 201
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 200
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 199
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 197
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 197
Electrolyte Disorders Induced by Antineoplastic Drugs 196
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 195
Lymphangiogenesis in genetically determined hypertrophic obstructive cardiomyopathy 191
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 190
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 189
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 188
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 187
The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice. 186
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 186
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 186
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 186
Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. 184
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 181
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 179
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors 178
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 178
Amelioration of cardiac electrical performance following stem cell based regenerative therapies, in infarcted rat heart 178
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 177
Aging and heart failure at the cellular and tissue levels. 177
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 176
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients 176
Repair of chronic myocardial infarction (MI) induced by mobilization of cardiac progenitor cells (CPCs) via local delivery of hapatocyte growth factor (HGF) and insulin-like growth factor-1 (IGF-1) is not proarrhythmic. 175
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 175
Development and validation of an high performance liquidchromatography–tandem mass spectrometry method for the determination of imatinib in rat tissues 173
Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease? 173
Myocyte cellular hypertrophy and hyperplasia contribute to ventricular wall remodeling in anemia-induced cardiac hypertrophy in rats 173
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 173
Microsfere polimeriche funzionalizzate per terapie rigenerative cardiache mediate da cellule staminali. Test di biocompatibilità in vitro e in vivo. 172
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 172
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 171
Mobilization of cardiac progenitor cells by Hepatocyte Growth Factor (HGF) and Insulin-like Growth Factor-1 (IGF-1) for repairing chronic myocardial infarction (MI) is not proarrhytmic. 170
Hystone deacetylase inhibitors (HDACi) ameliorate cardiac elctrical competence in mdx mouse model of Duchenne muscular dystrophy (DMD). 170
Deacetylase inhibitors reduce cardiac arrhythmogenesis in mdx mouse model of duchenne muscular dystrophy (DMD). 169
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 169
Resveratrol Treatment Reduces Cardiac Progenitor Cell Dysfunction and Prevents Morpho-Functional Ventricular Remodeling in Type-1 Diabetic Rats 168
Cardiac regeneration by pharmacologically active microcarriers releasing growth factors and/or transporting adipose-derived stem cells 168
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 167
Adult osteopetrosis: study of two brothers. 167
Trimethylamine-N-Oxide (TMAO)-Induced Impairment of Cardiomyocyte Function and the Protective Role of Urolithin B-Glucuronide 167
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 165
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 165
Imatinib Mesylate Induced Cardiotoxicity: a Cardiac Progenitor Cell Disease? 164
Competenza funzionale elettrica del cuore rigenerato mediante mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardico cronico. 163
"Identification of differential resistance/sensitivity cellular mechanisms triggered by Gentuzumab Ozogamicin in Acute Myeloid Leukemia 163
Isolation and characterization of human lung lymphatic endothelial cells 162
Assessment of Cardiac Patches Suitability for Tissue Engineering 162
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN 162
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens 161
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 160
1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients 160
Long-term effects of prenatal stress: changes in adult cardiovascular regulation and sensitivity to stress 160
Cardiac regeneration by pharmacologically active microcarriers releasing growth factors and/or transporting adipose-derived stem cells 160
Dissecting the cellular mechanisms of cardiotoxicity by anthracycline and tyrosine kinase inhibitors 160
Potential involvement of cardiac and bone marrow vascular progenitors in imatinib induced cardiovascular toxicity 158
Apoptosis in the Infarcted Human Heart 158
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 157
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 157
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity 156
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 156
PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors 156
Diabetes Impairs Bone Marrow Microenvironment Affecting Progenitor Cell Number, Mobilization and Engraftment in Humans. 155
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 155
Electro-mechanical competence of regenerated heart in stem cell based therapy of myocardial infarction in rat model. 155
Cardiac electromechanical performance following stem cell based regenerative therapies in infarcted rat heart. 155
Social defeat and isolation induce clear signs of a depression-like state, but modest cardiac alterations in wild-type rats. 153
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 153
Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns acquired resistance to immunotherapy in patients with NSCLC 152
Diabetes mellitus induces bone marrow microangiopathy 152
High-resolution X-ray microtomography for three-dimensional imaging of cardiac progenitor cell homing in infarcted rat hearts 150
Time-course transcriptome analysis of a double challenge bleomycin-induced lung fibrosis rat model uncovers ECM homoeostasis-related translationally relevant genes 149
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 149
Totale 18.860
Categoria #
all - tutte 136.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.198 0 40 22 73 35 26 187 165 52 81 101 416
2022/20235.406 541 576 381 378 519 609 88 334 1.673 17 207 83
2023/20242.138 111 170 48 66 190 518 196 141 74 148 179 297
2024/20256.683 155 360 480 463 700 624 326 337 771 581 545 1.341
2025/202615.259 1.289 1.357 1.879 1.420 1.962 770 1.564 551 2.139 1.159 679 490
2026/20271.048 388 660 0 0 0 0 0 0 0 0 0 0
Totale 39.774